Odtuhan, Jimmy M.

HRN: 21-32-36  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/10/2022
CEFTRIAXONE 1G (VIAL)
05/10/2022
05/17/2022
IV
2g
Q12
Bacterial Meningitis
Waiting Final Action 
05/18/2022
CEFTRIAXONE 1G (VIAL)
05/18/2022
05/25/2022
IV
2G
Q12H
Acute Bacterial Meningitis
Waiting Final Action 
05/25/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/25/2022
06/01/2022
IV
500mg
Q8H
Acute Bacterial Meningitis
Waiting Final Action 
05/25/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/25/2022
06/01/2022
IV
4.5 Loading Dose Then 2.25g Q8h
Q8h
Acute Bacterial Meningitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: